Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-015633
Filing Date
2018-03-19
Accepted
2018-03-19 16:54:29
Documents
1
Period of Report
2018-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv488937_form4.html 4  
1 FORM 4 tv488937_form4.xml 4 5993
  Complete submission text file 0001144204-18-015633.txt   7402
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
RAYNOR DANIEL (Reporting) CIK: 0001068854 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 18699435